Allergan, Alcon Settle Patent Feud Over Eye Drops
Botox manufacturer Allergan Inc. and Alcon Inc. have amicably ended a patent infringement battle that has lasted nearly two years over Alcon's brimonidine 0.15% eye drops product....To view the full article, register now.
Already a subscriber? Click here to view full article